U.S. Digital Therapeutics Market, By Application ((Treatment & Disease Management (Chronic Care, Mental Health & Neurological Disorders, and Others) and Preventive Care (Pre-diabetes, Weight Management, and Others)) and By End User (Healthcare Providers, Patients/Individuals, Payers, Employers, and Others)-

Published In : May 2023

Code : CMI5690

Pages :157

Formats :

Excel and PDF

Industry : Healthcare IT

U.S. Digital Therapeutics MarketSize and Trends

The U.S. Digital Therapeutics Market was valued at US$ 2.11 Bn in 2022 and is forecast to reach a value of US$ 21.46 Bn by 2030 at a CAGR of 33.8% between 2023 and 2030. The U.S. Digital Therapeutics Market is experiencing strong growth due to the rise in burden of chronic diseases and the outbreak of COVID-19 (pandemic). Moreover, growing adoption of digital healthcare and rise in adoption of novel technologies is expected to boost growth of the market. However, factors such as growing concerns about patient data privacy and challenges involved with digital therapeutics are expected to hamper growth of the U.S. Digital Therapeutics Market.

Market Trends:

Rise in focus towards preventive healthcare is a recent trend

Mobile Health (mHealth) is the use of mobile and wireless technologies to support the achievement of health objectives. The most common application of mobile health is the use of mobile devices to educate consumers about preventive healthcare services...

Government initiatives to digitalize healthcare is another trend

Digital transformation in the healthcare industry means digitizing processes and products to deliver better healthcare services along with improved customer experience. The digital revolution in the healthcare in the U.S. is marching steadily forward, spurred by the federal government regulations, financial incentives and technological innovations...